These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19025098)

  • 1. Alkaloids with antiprotozoal activity.
    Osorio EJ; Robledo SM; Bastida J
    Alkaloids Chem Biol; 2008; 66():113-90. PubMed ID: 19025098
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 3. Parasitology. Drugs to combat tropical protozoan parasites.
    Gelb MH; Hol WG
    Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
    [No Abstract]   [Full Text] [Related]  

  • 4. Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria.
    Scarim CB; Jornada DH; Machado MGM; Ferreira CMR; Dos Santos JL; Chung MC
    Eur J Med Chem; 2019 Jan; 162():378-395. PubMed ID: 30453246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparasitic therapy.
    Kappagoda S; Singh U; Blackburn BG
    Mayo Clin Proc; 2011 Jun; 86(6):561-83. PubMed ID: 21628620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiprotozoal compounds: state of the art and new developments.
    Astelbauer F; Walochnik J
    Int J Antimicrob Agents; 2011 Aug; 38(2):118-24. PubMed ID: 21549569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Potential of Natural Products as Antiparasitic Agents for Neglected Tropical Diseases.
    Orosco D; Mendoza AR; Meléndez CM
    Curr Top Med Chem; 2024; 24(2):89-108. PubMed ID: 37842892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
    Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
    Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
    Takasu K
    Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
    Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
    PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 13. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
    Bouchikhi F; Anizon F; Brun R; Moreau P
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.
    Espuelas S; Plano D; Nguewa P; Font M; Palop JA; Irache JM; Sanmartín C
    Curr Med Chem; 2012; 19(25):4259-88. PubMed ID: 22834813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel benzamidine- and guanidine-derived polyazamacrocycles: Selective anti-protozoal activity for human African trypanosomiasis.
    Reid CM; Ebikeme C; Barrett MP; Patzewitz EM; Müller S; Robins DJ; Sutherland A
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5399-401. PubMed ID: 18829314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
    Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
    Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemotherapy of protozoal infections: whither?
    Steck EA
    J Protozool; 1981 Feb; 28(1):30-5. PubMed ID: 6265632
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug discovery for the treatment of leishmaniasis, African sleeping sickness and Chagas disease.
    Future Med Chem; 2013 Oct; 5(15):1709-18. PubMed ID: 24144408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria.
    Tempone AG; Pieper P; Borborema SET; Thevenard F; Lago JHG; Croft SL; Anderson EA
    Nat Prod Rep; 2021 Dec; 38(12):2214-2235. PubMed ID: 34913053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.